Prosecution Insights
Last updated: October 25, 2026

The University of Melbourne

Technology area: Biotechnology & Pharmaceuticals

12 pending office actions • 11 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Analysis

The University of Melbourne has 13 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 13 distinct examiners and 11 art units, showing broad examiner coverage with repeated activity within some art units. The equal pending-action and examiner figures indicate no repeated examiner assignment in the available profile.

JOS, BASIL T is the busiest examiner, with 1 pending matter. The docket is therefore better organized by technology and art unit than by recurring examiner. Portfolio counsel should maintain consistent disclosure and claim objectives while adapting responses to the separate examination records.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

12
Total Pending OAs
11
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (58%)
5
Medium (42%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (8%)
§103 only2 (17%)
§102 only1 (8%)
Double-patenting + other2 (17%)
Multi-statute (no §101)6 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
58% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
8% of docket
3
Mechanical / Eng
25% of docket
1
Business / Other
8% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

120 h
Manual time on pending OAs
24 h
Time saved (low, 20%)
42 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JOS, BASIL T 1 78.0% +6.3%
LEE, SIN J 1 68.8% +25.1%
BERTRAM, ERIC D 1 81.3% +12.4%
STOCK JR, GORDON J 1 81.6% +17.4%
HANEY, JONATHAN MICHAEL 1 56.9% +54.5%
BLUMEL, BENJAMIN P 1 70.7% +30.6%
BOATENG, AFUA BAMFOAA 1 46.7% +64.5%
OGUNTADE, ELIZABETH BISOLA 1 50.0% +100.0%
O'KEEFE, SEAN P 1 65.6% +13.6%
DONOHUE, SEAN R 1 41.4% +21.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18949065 METHODS, SYSTEMS, AND APPARATUS FOR CLOSED-LOOP NEUROMODULATION BERTRAM, ERIC D —

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17922583 COPPER-CONTAINING THERAGNOSTIC COMPOSITIONS AND METHODS OF USE DONOHUE, SEAN R 15d overdue
18766377 EVANESCENT FIELD RESONANCE IMAGING MICROSCOPY APPARATUS AND METHOD STOCK JR, GORDON J —
18699932 BLOOD COLLECTION DEVICE HANEY, JONATHAN MICHAEL —
18294900 SELF-CLEAVING POLYPROTEINS AND USES THEREOF BLUMEL, BENJAMIN P —
18562459 METHODS FOR INDUCING VASODILATION BOATENG, AFUA BAMFOAA —
18462923 LIQUID PHASE SINTERED ALUMINUM ALLOY FOR BINDER JET PRINTING O'KEEFE, SEAN P —
17512812 Image Analysis for Breast Cancer Prognosis FONSECA LOPEZ, FRANCINI ALVARENGA —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17922583 COPPER-CONTAINING THERAGNOSTIC COMPOSITIONS AND METHODS OF USE DONOHUE, SEAN R 15d overdue
19028247 COMPLEXES FOR TREATING SENSITIVITY LEE, SIN J —
18949065 METHODS, SYSTEMS, AND APPARATUS FOR CLOSED-LOOP NEUROMODULATION BERTRAM, ERIC D —
18766377 EVANESCENT FIELD RESONANCE IMAGING MICROSCOPY APPARATUS AND METHOD STOCK JR, GORDON J —
18699932 BLOOD COLLECTION DEVICE HANEY, JONATHAN MICHAEL —
18294900 SELF-CLEAVING POLYPROTEINS AND USES THEREOF BLUMEL, BENJAMIN P —
18562459 METHODS FOR INDUCING VASODILATION BOATENG, AFUA BAMFOAA —
18285490 MULTIPLEX IMMUNOASSAY FOR THE DETECTION OF MYCOPLASMA BOVIS INFECTION OGUNTADE, ELIZABETH BISOLA —

Top Art Units

Art UnitApps
3658 1
1613 1
3796 1
2877 1
3791 1
1617 1
1677 1
1738 1
1618 1
1685 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19175898 MEDICAL DEVICE FOR SENSING AND OR STIMULATING TISSUE JOS, BASIL T 3658 §103 Non-Final OA — Pending Apr 10, 2025
19028247 COMPLEXES FOR TREATING SENSITIVITY LEE, SIN J 1613 §103DP Non-Final OA — Pending Jan 17, 2025
18949065 METHODS, SYSTEMS, AND APPARATUS FOR CLOSED-LOOP NEUROMODULATION BERTRAM, ERIC D 3796 §102 Non-Final OA — Pending Nov 15, 2024
18766377 EVANESCENT FIELD RESONANCE IMAGING MICROSCOPY APPARATUS AND METHOD STOCK JR, GORDON J 2877 §102§103§112Other Non-Final OA — Pending Jul 08, 2024
18699932 BLOOD COLLECTION DEVICE HANEY, JONATHAN MICHAEL 3791 §102§103§112 Non-Final OA — Pending Apr 10, 2024
18294900 SELF-CLEAVING POLYPROTEINS AND USES THEREOF BLUMEL, BENJAMIN P — §102§103§112Other Non-Final OA — Pending Feb 02, 2024
18562459 METHODS FOR INDUCING VASODILATION BOATENG, AFUA BAMFOAA 1617 §102§103§112Other Non-Final OA — Pending Nov 20, 2023
18285490 MULTIPLEX IMMUNOASSAY FOR THE DETECTION OF MYCOPLASMA BOVIS INFECTION OGUNTADE, ELIZABETH BISOLA 1677 §102§103§112DP Non-Final OA — Pending Oct 03, 2023
18462923 LIQUID PHASE SINTERED ALUMINUM ALLOY FOR BINDER JET PRINTING O'KEEFE, SEAN P 1738 §102§103 Non-Final OA — Pending Sep 07, 2023
17922583 COPPER-CONTAINING THERAGNOSTIC COMPOSITIONS AND METHODS OF USE DONOHUE, SEAN R 1618 §103§112 Non-Final OA 15d overdue Pending Oct 31, 2022
17512812 Image Analysis for Breast Cancer Prognosis FONSECA LOPEZ, FRANCINI ALVARENGA 1685 §101§112 Non-Final OA — Pending Oct 28, 2021
17438299 CONCEALMENT OF HYPOMINERALISED LESIONS ROBERTS, LEZAH 1612 §103Other Non-Final OA 3d overdue Pending Sep 10, 2021

Managing The University of Melbourne's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does The University of Melbourne have?

The University of Melbourne has 12 pending office actions as of October 2026, spread across 11 art units and 12 examiners.

Which USPTO examiner handles the most The University of Melbourne applications?

Basil T Jos has the most, with 1 of The University of Melbourne's pending office actions.

What technology area are The University of Melbourne's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month